As of 2025-01-18, the EV/EBITDA ratio of AngioDynamics Inc (ANGO) is -101.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ANGO's latest enterprise value is 450.94 mil USD. ANGO's TTM EBITDA according to its financial statements is -4.43 mil USD. Dividing these 2 quantities gives us the above ANGO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.5x - 17.5x | 16.8x |
| Forward P/E multiples | 14.5x - 23.1x | 17.6x |
| Fair Price | (0.25) - (0.58) | (0.55) |
| Upside | -102.0% - -104.6% | -104.4% |
| Date | EV/EBITDA |
| 2025-01-13 | -102.89 |
| 2025-01-10 | -100.65 |
| 2025-01-08 | -106.52 |
| 2025-01-07 | -74.04 |
| 2025-01-06 | -72.84 |
| 2025-01-03 | -71.10 |
| 2025-01-02 | -70.18 |
| 2024-12-31 | -71.83 |
| 2024-12-30 | -70.82 |
| 2024-12-27 | -69.54 |
| 2024-12-26 | -70.46 |
| 2024-12-24 | -67.52 |
| 2024-12-23 | -69.08 |
| 2024-12-20 | -69.36 |
| 2024-12-19 | -66.51 |
| 2024-12-18 | -69.72 |
| 2024-12-17 | -72.75 |
| 2024-12-16 | -73.39 |
| 2024-12-13 | -70.37 |
| 2024-12-12 | -72.02 |
| 2024-12-11 | -71.38 |
| 2024-12-10 | -69.36 |
| 2024-12-09 | -66.97 |
| 2024-12-06 | -52.01 |
| 2024-12-05 | -52.93 |
| 2024-12-04 | -53.30 |
| 2024-12-03 | -52.93 |
| 2024-12-02 | -53.30 |
| 2024-11-29 | -51.37 |
| 2024-11-27 | -52.20 |
| 2024-11-26 | -51.92 |
| 2024-11-25 | -51.92 |
| 2024-11-22 | -50.45 |
| 2024-11-21 | -51.56 |
| 2024-11-20 | -49.63 |
| 2024-11-19 | -49.45 |
| 2024-11-18 | -50.91 |
| 2024-11-15 | -50.27 |
| 2024-11-14 | -50.64 |
| 2024-11-13 | -51.92 |
| 2024-11-12 | -53.30 |
| 2024-11-11 | -56.05 |
| 2024-11-08 | -53.85 |
| 2024-11-07 | -53.39 |
| 2024-11-06 | -55.78 |
| 2024-11-05 | -51.92 |
| 2024-11-04 | -49.63 |
| 2024-11-01 | -49.08 |
| 2024-10-31 | -49.17 |
| 2024-10-30 | -51.37 |